Ποια είναι η τιμή για Catalent, Inc. (CTLT)

Η τιμή για Catalent, Inc. (CTLT) είναι $63.48

Ποια είναι η κεφαλαιοποίηση αγοράς για Catalent, Inc. (CTLT)

Η κεφαλαιοποίηση αγοράς για Catalent, Inc. (CTLT) είναι $11.52B

Catalent, Inc. (CTLT) Μετοχές σε Κυκλοφορία

Catalent, Inc., operating globally through its various subsidiaries, specializes in the development and production of comprehensive solutions for a wide array of products, including pharmaceutical drugs, protein-based biologics, advanced cell and gene therapies, and consumer health items. The company's operations are strategically divided into four key segments: Biologics; Softgel and Oral Technologies; Oral and Specialty Delivery; and Clinical Supply Services. The Softgel and Oral Technologies division focuses on the formulation, development, and manufacturing of soft capsules. These are utilized in a diverse range of client products, such as prescription medications, over-the-counter drugs, nutritional supplements, unit-dose cosmetics, and medicinal preparations for animal health. Within the Biologics segment, Catalent undertakes the creation of biologic cell lines, develops and manufactures both cell therapy and viral-based gene therapy, and handles the formulation and production of parenteral dose forms, including vials, prefilled syringes, and cartridges. This segment also provides essential analytical development and testing capabilities. The Oral and Specialty Delivery segment offers extensive formulation, development, and manufacturing expertise across various technologies. It provides integrated downstream solutions spanning clinical development and commercial supply. This segment also features a dedicated oral delivery solutions platform, encompassing preclinical screening, formulation, analytical development, and current good manufacturing practices (cGMP) services. Finally, the Clinical Supply Services segment delivers vital support for drug and biologic clinical trials. Its services include manufacturing, specialized packaging, secure storage, efficient distribution, and comprehensive inventory management. This segment also offers "FastChain," a demand-led clinical supply service. Catalent serves a broad client base, including pharmaceutical, biotechnology, and consumer health organizations, alongside companies in other healthcare sectors like animal health and medical devices, and even the cosmetics industry. The company was founded in 2007 and maintains its headquarters in Somerset, New Jersey.

Έτος	Κυκλοφορούντες μετοχές	Αλλαγή
2026 (TTM)	182.00M	0.55%
2024	181.00M	0.00%
2023	181.00M	2.84%
2022	176.00M	4.76%
2021	168.00M	12.15%
2020	149.79M	3.85%
2019	144.25M	9.94%
2018	131.20M	4.96%
2017	125.00M	0.16%
2016	124.80M	4.10%
2015	119.89M	2.20%
2014	117.30M	-0.02%
2013	117.32M	0.00%
2012	117.32M	0.00%
2011	117.32M	0.00%

Έτος

Κυκλοφορούντες μετοχές

Αλλαγή

2026 (TTM)

182.00M

0.55%

2024

181.00M

0.00%

2023

181.00M

2.84%

2022

176.00M

4.76%

2021

168.00M

12.15%

2020

149.79M

3.85%

2019

144.25M

9.94%

2018

131.20M

4.96%

2017

125.00M

0.16%

2016

124.80M

4.10%

2015

119.89M

2.20%

2014

117.30M

-0.02%

2013

117.32M

0.00%

2012

117.32M

0.00%

2011

117.32M

0.00%

Εταιρεία	Κυκλοφορούντες μετοχές	Διαφορά	Χώρα
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	2.40B	1,218.32%	IN

Εταιρεία

Κυκλοφορούντες μετοχές

Διαφορά

Χώρα